Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
15757 | 624 | 50.4 | 94% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1728 | 6064 | ACUTE PROMYELOCYTIC LEUKEMIA//ARSENIC TRIOXIDE//SUMO |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | DAXX | Author keyword | 51 | 54% | 11% | 66 |
2 | PML | Author keyword | 28 | 20% | 20% | 122 |
3 | PML NUCLEAR BODIES | Author keyword | 17 | 54% | 4% | 22 |
4 | ND10 | Author keyword | 15 | 56% | 3% | 18 |
5 | PROMYELOCYTIC LEUKEMIA PROTEIN | Author keyword | 14 | 55% | 3% | 18 |
6 | SP100 | Author keyword | 11 | 40% | 3% | 21 |
7 | PML NUCLEAR BODY | Author keyword | 9 | 55% | 2% | 11 |
8 | HDAXX | Author keyword | 8 | 75% | 1% | 6 |
9 | NUCLEAR BODIES | Author keyword | 7 | 20% | 5% | 30 |
10 | HUMAN GENETSLOAN KETTERING | Address | 6 | 80% | 1% | 4 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | DAXX | 51 | 54% | 11% | 66 | Search DAXX | Search DAXX |
2 | PML | 28 | 20% | 20% | 122 | Search PML | Search PML |
3 | PML NUCLEAR BODIES | 17 | 54% | 4% | 22 | Search PML+NUCLEAR+BODIES | Search PML+NUCLEAR+BODIES |
4 | ND10 | 15 | 56% | 3% | 18 | Search ND10 | Search ND10 |
5 | PROMYELOCYTIC LEUKEMIA PROTEIN | 14 | 55% | 3% | 18 | Search PROMYELOCYTIC+LEUKEMIA+PROTEIN | Search PROMYELOCYTIC+LEUKEMIA+PROTEIN |
6 | SP100 | 11 | 40% | 3% | 21 | Search SP100 | Search SP100 |
7 | PML NUCLEAR BODY | 9 | 55% | 2% | 11 | Search PML+NUCLEAR+BODY | Search PML+NUCLEAR+BODY |
8 | HDAXX | 8 | 75% | 1% | 6 | Search HDAXX | Search HDAXX |
9 | NUCLEAR BODIES | 7 | 20% | 5% | 30 | Search NUCLEAR+BODIES | Search NUCLEAR+BODIES |
10 | SUPRAMOLECULAR REGULATION | 4 | 75% | 0% | 3 | Search SUPRAMOLECULAR+REGULATION | Search SUPRAMOLECULAR+REGULATION |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SUPPRESSOR PML | 32 | 88% | 2% | 15 |
2 | TUMOR SUPPRESSOR PML | 28 | 81% | 3% | 17 |
3 | PROMYELOCYTIC LEUKEMIA PROTEIN | 26 | 32% | 11% | 68 |
4 | RAR ALPHA | 25 | 15% | 24% | 148 |
5 | NUCLEAR BODIES | 24 | 20% | 18% | 110 |
6 | NUCLEAR BODY FORMATION | 18 | 43% | 5% | 33 |
7 | ONCOGENIC DOMAINS PODS | 17 | 75% | 2% | 12 |
8 | ADAPTER PROTEIN DAXX | 13 | 67% | 2% | 12 |
9 | FAS BINDING PROTEIN | 12 | 75% | 1% | 9 |
10 | PML NUCLEAR BODIES | 12 | 25% | 7% | 41 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies | 2007 | 399 | 117 | 65% |
Regulation of apoptosis by PML and the PML-NBs | 2008 | 65 | 101 | 63% |
The role of PML in tumor suppression | 2002 | 323 | 26 | 69% |
PML and PML nuclear bodies: Implications in antiviral defence | 2007 | 190 | 135 | 41% |
Role of Promyelocytic Leukemia Protein in Host Antiviral Defense | 2011 | 55 | 120 | 45% |
New insights into the role of the subnuclear structure ND10 for viral infection | 2008 | 81 | 195 | 41% |
PML-mediated signaling and its role in cancer stem cells | 2014 | 3 | 161 | 55% |
PML nuclear bodies: dynamic sensors of DNA damage and cellular stress | 2004 | 213 | 93 | 49% |
PML control of cytokine signaling | 2014 | 3 | 79 | 51% |
PML nuclear bodies and apoptosis | 2004 | 120 | 74 | 62% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HUMAN GENETSLOAN KETTERING | 6 | 80% | 0.6% | 4 |
2 | ROY DIANA VAGELOS OLARS PROGRAM MOL LIFE SCI | 2 | 67% | 0.3% | 2 |
3 | GRP CELLULAR SENESCENCE | 2 | 33% | 0.6% | 4 |
4 | SLOAN KETTERING MOL BIOL PROGRAM | 1 | 38% | 0.5% | 3 |
5 | HAYEM CNRS UPR 43 | 1 | 100% | 0.3% | 2 |
6 | HOP ST LOUIS 1 | 1 | 50% | 0.3% | 2 |
7 | MEDCANC GENET PROGRAM | 1 | 50% | 0.3% | 2 |
8 | PROGRAM MOL BIOL MED SCI | 1 | 100% | 0.3% | 2 |
9 | FRE 3235 | 1 | 27% | 0.5% | 3 |
10 | SLOAN KETTERING HUMAN GENET | 1 | 33% | 0.3% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000204221 | ACUTE PROMYELOCYTIC LEUKEMIA//PML RAR ALPHA//APL |
2 | 0.0000203774 | SUMO//SUMOYLATION//UBC9 |
3 | 0.0000167506 | HIPK2//CACYBP SIP//CACYBP |
4 | 0.0000135840 | MARJORIE B KOVLER VIRAL ONCOL S//ICP27//ICP0 |
5 | 0.0000098894 | TRIM5 ALPHA//TRIMCYP//TRIM5 |
6 | 0.0000069209 | ASK1//PP5//APOPTOSIS SIGNAL REGULATING KINASE 1 |
7 | 0.0000065616 | NUCLEOLUS//COILIN//NUCLEOLOGENESIS |
8 | 0.0000061787 | ARSENIC TRIOXIDE//AS2O3//ARSENIC TRIOXIDE AS2O3 |
9 | 0.0000061019 | NEURONAL INTRANUCLEAR INCLUSION DISEASE//INTRANUCLEAR INCLUSION BODY DISEASE//NEURONAL INTRANUCLEAR HYALINE INCLUSION DISEASE |
10 | 0.0000057774 | ARID3B//JUMONJI//AT RICH INTERACTION DOMAIN |